{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:03:08Z","timestamp":1789416188646,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.adro.2026.102144","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:19:46Z","timestamp":1784330386000},"page":"102144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["From Clinical Trials to Clinical Practice\u2013Patterns of Practice Survey on Prostate SABR in Australia and New Zealand"],"prefix":"10.1016","volume":"11","author":[{"given":"Therese","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarat","family":"Chander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Finnigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suki","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Guerrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braden","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetu","family":"Tejani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedang","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Loblaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6657-7193","authenticated-orcid":false,"given":"Wee Loon","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2026.102144_bib0001","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer","volume":"391","author":"van As","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2026.102144_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030731","article-title":"TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol","volume":"9","author":"Martin","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.adro.2026.102144_bib0003","article-title":"Urethra contouring on computed tomography urethrogram versus magnetic resonance imaging for stereotactic body radiotherapy in prostate cancer","volume":"45","author":"Ong","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102144_bib0004","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/1754-9485.13806","article-title":"Radiotherapy for node-positive prostate cancer in the PSMA-PET era: The need for prospective clinical trials","volume":"69","author":"Ong","year":"2025","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102144_bib0005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.eururo.2024.08.030","article-title":"Radical prostatectomy versus stereotactic radiotherapy for clinically localised prostate cancer: Results of the PACE-A randomised trial","volume":"86","author":"van As","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2026.102144_bib0006","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1470-2045(25)00205-0","article-title":"Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): Early toxicity results from a randomised, open-label, phase 3, non-inferiority trial","volume":"26","author":"Tree","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102144_bib0007","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamaoncol.2022.6558","article-title":"Magnetic resonance imaging-guided vs computed tomography-guided stereotactic body radiotherapy for prostate cancer: The MIRAGE randomized clinical trial","volume":"9","author":"Kishan","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2026.102144_bib0008","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.eururo.2025.07.007","article-title":"Exploring factors associated with late urinary toxicity after prostate stereotactic body radiotherapy: Findings from the PACE-B study","volume":"89","author":"Ratnakumaran","year":"2026","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2026.102144_bib0009","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/bju.15821","article-title":"Comprehensive review of the use of hydrogel spacers prior to radiation therapy for prostate cancer","volume":"131","author":"Harvey","year":"2023","journal-title":"BJU Int"},{"key":"10.1016\/j.adro.2026.102144_bib0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamaoncol.2022.7592","article-title":"Hyaluronic acid spacer for hypofractionated prostate radiation therapy: A randomized clinical trial","volume":"9","author":"Mariados","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2026.102144_bib0011","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ijrobp.2023.03.057","article-title":"Every-other-day versus once-a-week urethra-sparing prostate stereotactic body radiation therapy: 5-year results of a randomized phase 2 trial","volume":"117","author":"Zilli","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102144_bib0012","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.euo.2025.03.011","article-title":"Every other day or once a week: Long-term oncological outcomes in the phase 2 PATRIOT trial of prostate stereotactic ablative body radiotherapy","volume":"8","author":"Ong","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.adro.2026.102144_bib0013","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2026.102144_bib0014","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1470-2045(25)00656-4","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial","volume":"27","author":"Nilsson","year":"2026","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102144_bib0015","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: Results from the FLAME randomized phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102144_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110568","article-title":"Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial","volume":"201","author":"Draulans","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102144_bib0017","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijrobp.2025.04.039","article-title":"PSMA MRI Guided prOstate SBRT (ARGOS)\/Comprehensive, Longitudinal Evaluation of IMaging BiomarkErs Post Radiotherapy (CLIMBER) phase I\/II trial","volume":"123","author":"Ramadan","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102144_bib0018","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ijrobp.2023.06.250","article-title":"To boost or not to boost: Pooled analyses from 2-fraction SABR trials for localized prostate cancer","volume":"117","author":"Ong","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102144_bib0019","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijrobp.2021.06.037","article-title":"Radiation dose to the intraprostatic urethra correlates strongly with urinary toxicity after prostate stereotactic body radiation therapy: A combined analysis of 23 prospective clinical trials","volume":"112","author":"Leeman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102144_bib0020","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/1754-9485.13552","article-title":"Patterns of practice regarding use of radiation therapy following radical prostatectomy: A survey of Radiation Oncologists and Urologists in Australia and New Zealand","volume":"67","author":"Lawless","year":"2023","journal-title":"J Med Imaging Radiat Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245210942600151X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245210942600151X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:00:43Z","timestamp":1787000443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S245210942600151X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S245210942600151X"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2026.102144","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From Clinical Trials to Clinical Practice\u2013Patterns of Practice Survey on Prostate SABR in Australia and New Zealand","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2026.102144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"102144"}}